anti-miR-574-5p antisense oligonucleotide (Xiamen University/Amoigen Bioscience)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Nameanti-miR-574-5p antisense oligonucleotide (Xiamen University/Amoigen Bioscience)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionImmunomodulatorsAntisense oligonucleotide inhibitors
TargetsUpdating
Therapy Area/IndicationsLupus Erythematosus, SystemicColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesXiamen University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmoigen Bioscience (Xiamen) Co LtdXiamen University
Active IndicationsN/A
Inactive IndicationsLupus Erythematosus, SystemicColonic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A